Vanderbilt University Medical Center

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Vanderbilt University Medical Center sits in the top decile of US sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count).

677 total trials 130 currently recruiting 400 completed early-phase tilt top decile by trial count

Vanderbilt University Medical Center: 677 sponsored US clinical trials, 130 recruiting.

Vanderbilt University Medical Center sponsors 677 registered US clinical trials on ClinicalTrials.gov, 130 of them currently recruiting, and 400 completed. 70 of these trials are in Phase 3-4 (later-stage) and 127 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Autonomic Failure, with 9 trials.

Top-decile sponsor footprint

Vanderbilt University Medical Center ranks in the top decile of sponsors by registered trial count (#51 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

D 54/100

400 of 467 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

677 total, page 3 of 14

RECRUITING NA

Cardiovascular Autonomic and Immune Mechanism of Post COVID-19 Tachycardia Syndrome

NCT05421208

RECRUITING Phase 1

Sympathetic Mechanisms in Obesity-Crossover Design

NCT05312892

RECRUITING

Prospective Phenotyping for Genetic Subtypes of Early-onset Atrial Fibrillation

NCT05190679

RECRUITING NA

Stress and Opioid Misuse Risk: The Role of Endogenous Opioid and Endocannabinoid Mechanisms

NCT05142267

RECRUITING NA

Addressing Disparities in Autism Spectrum Disorder Diagnosis Using a Direct-to-home Telemedicine Tool

NCT05047224

RECRUITING

Tennessee Alzheimer's Project

NCT05372172

RECRUITING

Longitudinal Impact of Stressors in Adults With Tourette Syndrome

NCT04851678

RECRUITING

Gut Microbiota in Metabolic Surgery

NCT05000996

RECRUITING NA

Corticostriatal Contributions to Parkinson's Disease Cognitive Impairment

NCT04715984

RECRUITING Phase 3

Goal-Directed Sedation in Mechanically Ventilated Infants and Children

NCT04801589

RECRUITING

Neural Correlates of Psychiatric Disorders

NCT04725409

RECRUITING NA

Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms

NCT04782830

RECRUITING Early Phase 1

Effect of Midodrine vs Abdominal Compression on Cardiovascular Risk Markers in Autonomic Failure Patients

NCT04620382

RECRUITING NA

Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure

NCT04502225

RECRUITING Phase 1

Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function

NCT02359825

RECRUITING

Sensory Symptoms in Tourette Syndrome

NCT03851484

RECRUITING Phase 1

Automated Abdominal Binder for Orthostatic Hypotension

NCT03482297

RECRUITING NA

Treatment of Supine Hypertension in Autonomic Failure (CPAP)

NCT03312556

RECRUITING

Clinical Outcomes of the ALPS Proximal Humerus Plating System

NCT03328650

RECRUITING NA

Utility of PCD Diagnostics to Improve Clinical Care

NCT03704207

RECRUITING NA

Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension

NCT03042988

RECRUITING Phase 1

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

NCT02897063

RECRUITING Phase 1

Hemodynamic Mechanisms of Abdominal Compression in the Treatment of Orthostatic Hypotension in Autonomic Failure

NCT02429557

RECRUITING

Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

NCT01734122

RECRUITING

Vanderbilt Memory and Aging Project

NCT05372159

RECRUITING

Hormonal, Metabolic, and Signaling Interactions in PAH

NCT01884051

RECRUITING

Mechanisms of Familial Pulmonary Fibrosis

NCT03437486

RECRUITING

Physiological Brain Atlas Development

NCT00575081

RECRUITING

Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants

NCT00898638

RECRUITING

Gastrointestinal Biomarkers in Tissue and Biological Fluid Samples From Colorectal Cancer Patients

NCT00899626

ACTIVE NOT RECRUITING

Evaluating the Shift From Intravenous to Subcutaneous Vedolizumab for Inflammatory Bowel Disease

NCT07123350

ACTIVE NOT RECRUITING NA

Clinical Decision Support to Identify Pediatric Patients With Undiagnosed Genetic Disease

NCT06744543

ACTIVE NOT RECRUITING NA

Art Therapy in Progressive Supranuclear Palsy

NCT06588673

ACTIVE NOT RECRUITING NA

Deceased Donor Kidney Storage at 10 Celsius Versus Conventional Storage

NCT07385651

ACTIVE NOT RECRUITING NA

Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT Using Integrated Intraprocedural Imaging

NCT06654271

ACTIVE NOT RECRUITING NA

Prevention of Malnutrition in Children With Sickle Cell Disease

NCT06397118

ACTIVE NOT RECRUITING NA

Health Coaching for Back Pain After Emergency Department Discharge

NCT06400602

ACTIVE NOT RECRUITING

Building Lipedema Research Resources

NCT06180850

ACTIVE NOT RECRUITING NA

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

NCT05735743

ACTIVE NOT RECRUITING NA

Neurophysiology Biomarkers of Cognitive Impairment Associated With Deep Brain Stimulation

NCT05933681

ACTIVE NOT RECRUITING NA

Adapting FAMS to Optimize CGM Use Among Emerging Adults With Type 1 Diabetes

NCT05854069

ACTIVE NOT RECRUITING Phase 2

Depressed Mood Improvement Through Nicotine Dosing-3 (Depressed MIND3) Extension

NCT05746546

ACTIVE NOT RECRUITING Early Phase 1

Effect of Donepezil on Speech Recognition in Cochlear Implant Users

NCT05438264

ACTIVE NOT RECRUITING NA

The ECMO-Free Trial

NCT05486559

ACTIVE NOT RECRUITING Phase 2

Hemodialysis.-Induced Hypotension Therapy for End Stage Kidney Disease

NCT05297786

ACTIVE NOT RECRUITING NA

VICE-MPRINT: Maternal and Pediatric Pharmacogenetics Survey

NCT05037305

ACTIVE NOT RECRUITING Phase 2

Randomized Controlled Trial of urinE chemiStry Guided aCute heArt faiLure treATmEnt (ESCALATE)

NCT04481919

ACTIVE NOT RECRUITING Phase 4

The Impact of Factor Xa Inhibition on Thrombosis, Platelet Activation, and Endothelial Function in Peripheral Artery Disease

NCT05009862

ACTIVE NOT RECRUITING NA

The Electronic Medical Records and GEnomics (eMERGE) Network Genomic Risk Assessment

NCT05277116

ACTIVE NOT RECRUITING

Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome

NCT05344599

← Previous Page 3 of 14 Next →

Phase Distribution

PhaseTrial count
Phase 1 65
Phase 2 62
Phase 3 14
Phase 4 56

What is open in the Vanderbilt University Medical Center pipeline

130 recruiting of 677 indexed (19% open); 400 completed (59%).

Phase mix: 70 late (III/IV) vs 127 early (I/II) (early-phase heavy).

Top condition: Autonomic Failure (9 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Vanderbilt University Medical Center: open-pipeline peers nationwide

Peers matched on 677 registered trials and 19% open enrollment, not the therapeutic-area sidebar.

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 01,0002,0003,000 12%14%16%18%20%22%24% Total trials Recruiting share Vanderbilt University Medical CenterThe Cleveland ClinicUniversity of California, DavisWeill Medical College of Cornell UniversityIcahn School of Medicine at Mount SinaiCalifornia Polytechnic State University-San Luis ObispoPhoenix Children's HospitalMayo ClinicUniversity of South Carolina
Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Vanderbilt University Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 677 trials (± recruiting share)

Sponsors near 19% open enrollment (± trial volume)

What to do with this Vanderbilt University Medical Center page

677 registered trials is a research-attention snapshot, not an endorsement of Vanderbilt University Medical Center or any single study.

  • 130 of Vanderbilt University Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Autonomic Failure is the condition Vanderbilt University Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Autonomic Failure trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Vanderbilt University Medical Center pipeline card: 677 registered trials from official public datasets.Report a data error.